Search AI Products and News

Recently, global entertainment giants Disney and Universal Pictures have filed a copyright lawsuit against artificial intelligence company Midjourney, marking the first official legal dispute involving generative artificial intelligence for major Hollywood companies, drawing global attention. According to reports by CCTV, the two companies pointed out in their 110-page complaint that Midjourney allegedly illegally used its massive copyright library to generate and spread a large number of unauthorized copies of well-known characters, including characters from 'Star Wars,' 'Minions,' 'Shrek,' 'Frozen,' etc.

Insilico Medicine, a biopharmaceutical company focused on generative artificial intelligence, today announced the successful completion of a $110 million Series E financing round. The round was led by a private equity fund under Value Partners Group (HKG:0806), Pudong New Area Investment, Shanghai Pudong Development Bank Group, Xicheng Capital, and Yixing Guokong. Several new investors focused on the industry and technology sectors also participated, alongside continued support from existing investors.

Insilico Medicine recently announced the closing of a $110 million Series E financing round, led by Value Partners, a Hong Kong-based firm, with participation from existing and new investors. The funds will be used to refine the company's AI models and support pivotal clinical trials for its lead candidate drug in idiopathic pulmonary fibrosis. The company's small molecule inhibitor, ISM001-055, was recently officially named rentosertib by the U.S. Adopted Names Council, marking a significant milestone for this AI-generated drug candidate.

According to the latest data from analysis company Dealroom, funding for AI startups reached $110 billion in 2024, representing a 62% increase from last year. In contrast, the overall funding situation in the tech industry was less favorable, with the total amount of funding for private equity-backed companies (including startups and growth companies) amounting to $227 billion, a 12% decrease from 2023. Image source note: The image was generated by AI, image licensed from Midjourney. Dealroom founder.

Swiss robotics company Anybotics has recently announced an additional investment of $60 million in its Series B funding, bringing the total raised in this round to $110 million. This follows just 18 months after the company first announced receiving $50 million in Series B funding. Anybotics was spun off from ETH Zurich in 2016, focusing on the development of a quadrupedal autonomous inspection robot called Anymal. Anymal is equipped with various sensors.

Amazon recently announced a $110 million investment in AI research to support the development of its own designed Trainium chips. This move aims to reduce Amazon's reliance on Nvidia and promote technological advancements in its cloud computing platform AWS. Note: Image generated by AI, image licensed from service provider Midjourney. Trainium is a machine learning chip tailored for deep learning training and inference tasks. Through this investment, Amazon hopes to encourage academic research.

Recently, Amazon announced a significant investment of $110 million for artificial intelligence (AI) research aimed at reducing reliance on Nvidia and advancing the development of its own chips. The funding will support generative AI research at universities under the project name 'Build on Trainium.' The project will provide researchers with the opportunity to use Trainium chips to develop new AI architectures, machine learning libraries, and solutions for large-scale distributed AWS Train.

Munich-based drone manufacturer Quantum Systems has recently completed a new Series B funding round, securing new investments from ion Capital and Porsche Holding. This funding round raised over $110 million, initially targeted at $71 million, primarily led by HV Capital and DTCP, with subsequent interest from Project A, Thiel Capital, and Bavaria Growth Capital.